In the pharmaceutical industry, many rebate contract managers spend hundreds of hours manually identifying key data points from thousands of contracts. Rebate contracts can impact…
As Life Sciences companies comes to rely increasingly on digital capabilities and good data for efficiency and competitive advantage, it’s critical that they harness system…
Medical writing in pharma is ripe for disruption, across use cases linked to regulatory documentation and safety report summaries, and Generative AI (GenAI) promises exactly…
Companies are overcoming challenges to develop, launch, and educate on new rare disease medicines and treatment faster. Rare diseases are no longer rare. Every year,…
Drug research and development can cost up to $6bn per asset and take an average of 13 years from discovery to approval1. In this expensive…
Smart automation promises to transform life sciences research and development operations, and streamline pharma companies’ path to market while enhancing patient safety. But how far…
The new Third-Party Audit Report Library (3PARL®) consortium, founded by Rephine and Eurofins Healthcare, aims to set a benchmark for life sciences manufacturing supply chain…
The long-awaited eCTD 4.0 standard is now available, though it is not yet mandatory. Life sciences companies can tap into the detail of the standard…
A multimode plate reader is a device used to read and analyse culture or test plates in biological or chemical experiments, it can detect two…
Decentralised clinical trials (DCTs) are not new, though their popularity and utilisation has grown since the COVID-19 pandemic. DCTs are enabled by and mutually reinforce…
